Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.

Kupferman ME, Jiffar T, El-Naggar A, Yilmaz T, Zhou G, Xie T, Feng L, Wang J, Holsinger FC, Yu D, Myers JN.

Oncogene. 2010 Apr 8;29(14):2047-59. doi: 10.1038/onc.2009.486. Epub 2010 Jan 18.

2.

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.

Yu J, Xie F, Bao X, Chen W, Xu Q.

Mol Cancer. 2014 May 24;13:121. doi: 10.1186/1476-4598-13-121.

3.

Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.

Zhu L, Werner JA, Mandic R.

Anticancer Res. 2007 Sep-Oct;27(5A):3121-6.

4.

Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.

Bao W, Qiu H, Yang T, Luo X, Zhang H, Wan X.

PLoS One. 2013 Jul 30;8(7):e70616. doi: 10.1371/journal.pone.0070616. Print 2013.

5.

A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.

Lee J, Jiffar T, Kupferman ME.

PLoS One. 2012;7(1):e30246. doi: 10.1371/journal.pone.0030246. Epub 2012 Jan 20.

6.

RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.

Tumur Z, Katebzadeh S, Guerra C, Bhushan L, Alkam T, Henson BS.

Neoplasia. 2015 Jan;17(1):141-51. doi: 10.1016/j.neo.2014.12.002.

7.

Transcriptional profiling identifies upregulated genes following induction of epithelial-mesenchymal transition in squamous carcinoma cells.

Humtsoe JO, Koya E, Pham E, Aramoto T, Zuo J, Ishikawa T, Kramer RH.

Exp Cell Res. 2012 Feb 15;318(4):379-90. doi: 10.1016/j.yexcr.2011.11.011. Epub 2011 Nov 29.

PMID:
22154512
8.

Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma.

St John MA, Dohadwala M, Luo J, Wang G, Lee G, Shih H, Heinrich E, Krysan K, Walser T, Hazra S, Zhu L, Lai C, Abemayor E, Fishbein M, Elashoff DA, Sharma S, Dubinett SM.

Clin Cancer Res. 2009 Oct 1;15(19):6018-27. doi: 10.1158/1078-0432.CCR-09-0011. Epub 2009 Sep 29.

10.

Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.

St John MA.

Laryngoscope. 2015 Mar;125 Suppl 3:S1-11. doi: 10.1002/lary.24998. Epub 2015 Feb 3.

PMID:
25646683
11.
12.

N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.

Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, Takata T.

Histol Histopathol. 2011 Feb;26(2):147-56. doi: 10.14670/HH-26.147.

PMID:
21154228
13.

Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.

Rasanen K, Sriswasdi S, Valiga A, Tang HY, Zhang G, Perego M, Somasundaram R, Li L, Speicher K, Klein-Szanto AJ, Basu D, Rustgi AK, Speicher DW, Herlyn M.

Mol Cell Proteomics. 2013 Dec;12(12):3778-92. doi: 10.1074/mcp.M113.029587. Epub 2013 Sep 13.

14.

JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.

Hyakusoku H, Sano D, Takahashi H, Hatano T, Isono Y, Shimada S, Ito Y, Myers JN, Oridate N.

J Exp Clin Cancer Res. 2016 Jan 12;35:6. doi: 10.1186/s13046-016-0284-4.

15.

Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC.

Yilmaz T, Jiffar T, de la Garza G, Lin H, Milas Z, Takahashi Y, Hanna E, MacIntyre T, Brown JL, Myers JN, Kupferman ME.

Cancer Biol Ther. 2010 Sep 15;10(6):644-53. doi: 10.4161/cbt.10.6.12782. Epub 2010 Sep 23.

16.

Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.

Cameron S, de Long LM, Hazar-Rethinam M, Topkas E, Endo-Munoz L, Cumming A, Gannon O, Guminski A, Saunders N.

Mol Cancer. 2012 Sep 28;11:74. doi: 10.1186/1476-4598-11-74.

17.

CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.

Chen YS, Wu MJ, Huang CY, Lin SC, Chuang TH, Yu CC, Lo JF.

PLoS One. 2011;6(11):e28053. doi: 10.1371/journal.pone.0028053. Epub 2011 Nov 28.

18.

A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis.

Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS.

Mol Cell Biol. 2009 Jul;29(13):3722-37. doi: 10.1128/MCB.01164-08. Epub 2009 May 4.

19.

Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.

Xu J, Lu W, Zhang S, Zhu C, Ren T, Zhu T, Zhao H, Liu Y, Su J.

Cancer Biol Ther. 2014 May;15(5):612-22. doi: 10.4161/cbt.28181. Epub 2014 Feb 20.

20.

Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells.

Yang WH, Lan HY, Tai SK, Yang MH.

Biochem Biophys Res Commun. 2013 Mar 29;433(1):24-30. doi: 10.1016/j.bbrc.2013.02.076. Epub 2013 Feb 26.

PMID:
23454123

Supplemental Content

Support Center